What Cancers Cause Shortness of Breath?

Nearly every type of cancer can cause shortness of breath at some point during the disease, but certain cancers do so far more often and through more direct routes than others. Lung cancer is the most obvious culprit, yet breast cancer, melanoma, pancreatic cancer, blood cancers, and many others can leave a person struggling for air, sometimes as the very first symptom that sends them to a doctor. The mechanisms range from a tumor physically blocking an airway to fluid collecting where it should not be, to the body’s own response to cancer draining it of oxygen-carrying capacity. Understanding which cancers cause breathlessness and how they do it matters both for recognizing warning signs early and for knowing what can be done about them.

Cancers That Start in the Lungs

Primary lung cancer is the single most common malignancy behind cancer-related shortness of breath, and the connection is intuitive: a tumor growing inside the lung directly interferes with the organ’s ability to exchange oxygen and carbon dioxide. Non-small cell lung cancer and small cell lung cancer can both cause breathlessness, whether the tumor is a small peripheral nodule that triggers no symptoms at first or a large central mass pressing on a major airway. In some patients, multiple tumors appear in both lungs simultaneously. One case report described a 75-year-old former smoker whose progressive fatigue and shortness of breath led to a chest CT revealing three separate suspicious lesions spread across both lungs.1Cureus. Synchronous Primary Lung Cancer: An Unusual Triple Presentation That kind of presentation underscores how breathlessness can be the symptom that finally prompts imaging and uncovers a diagnosis.

Mesothelioma, a cancer arising from the lining of the lungs rather than the lung tissue itself, is another primary thoracic malignancy closely tied to breathing difficulty. Around 90% of mesothelioma cases develop a malignant pleural effusion, which is a buildup of fluid between the lung and the chest wall that compresses the lung and makes each breath shallower.2European Respiratory Society (Breathe). Malignant pleural disease – Section: Introduction

Cancers That Spread to the Lungs

The lungs are one of the most common destinations for cancer that has spread from elsewhere in the body. Blood passes through the lungs constantly, which means cancer cells circulating in the bloodstream often lodge there. Melanoma, colon cancer, kidney cancer, breast cancer, and sarcomas are among the many types that frequently metastasize to the lungs. When these secondary tumors grow large enough, they displace functional lung tissue and trigger the same breathing problems a primary lung tumor would.

A case study of a woman with metastatic melanoma illustrates how this unfolds over time. After initial treatment for a groin mass, she developed two lung nodules detected on a PET scan. Despite surgical removal of one nodule, follow-up imaging revealed multiple new lesions in both lungs, and her shortness of breath worsened progressively, especially during physical activity like gardening or bending over.3Europe PMC. Breathlessness with pulmonary metastases: a multimodal approach Her experience is typical of metastatic lung disease: breathlessness that starts mild and situational, then grows more constant as the tumor burden increases.

Fluid Where It Should Not Be

Two types of abnormal fluid collection account for a large share of cancer-related breathlessness, and they involve different body cavities.

Malignant Pleural Effusion

A malignant pleural effusion is fluid that accumulates in the space between the lung and the chest wall because cancer has invaded or irritated the pleural membranes. Even a moderate amount of fluid can compress the lung enough to make breathing noticeably harder. Lung cancer and breast cancer together account for roughly half to two-thirds of all malignant pleural effusions.2European Respiratory Society (Breathe). Malignant pleural disease – Section: Introduction Ovarian cancer, lymphoma, and gastrointestinal cancers also cause them, though less frequently. Treatment often involves draining the fluid and sometimes placing an indwelling catheter or performing a procedure to seal the pleural space so fluid cannot reaccumulate.

Malignant Pericardial Effusion

Less commonly, fluid builds up around the heart instead of the lungs, a condition called pericardial effusion. When cancer is responsible, the fluid can accumulate rapidly and compress the heart to the point where it cannot fill properly, a life-threatening situation called cardiac tamponade. One case report documented a woman with recurrent endometrial cancer who developed acute shortness of breath, rapid heart rate, and dangerously low blood pressure fourteen months after completing chemotherapy and radiation. An echocardiogram confirmed massive pericardial effusion requiring emergency drainage.4Journal of the Medical Association of Thailand. The Case Report of Malignant Pericardial Effusion in Recurrent Endometrial Cancer: An Emergency Treatable Condition – Section: Abstract Lung cancer, breast cancer, lymphoma, and leukemia are among the cancers most likely to cause this complication.

When a Tumor Blocks the Airway

Malignant central airway obstruction occurs when a tumor grows into or presses on the trachea or one of the main bronchi, the large airways that channel air into the lungs. This can happen with primary lung cancers or with cancers that have spread to the chest from other sites. The symptoms are often mistaken for asthma or chronic obstructive pulmonary disease because wheezing, cough, and shortness of breath overlap substantially. Diagnosis can be delayed for exactly that reason, though heightened suspicion and newer imaging techniques have improved detection.5Europe PMC. Overview of malignant central airway obstruction – Section: Abstract

A related scenario is superior vena cava syndrome, in which a tumor compresses the large vein that carries blood from the upper body back to the heart. This causes swelling in the face, neck, and arms along with shortness of breath. Lung cancer is the most frequent cause, and the obstruction can also involve the pulmonary artery. One documented case involved a sarcomatoid lung cancer that produced a large mediastinal mass compressing both the superior vena cava and the pulmonary artery simultaneously.6PubMed Central. An Atypical Case of Superior Vena Cava Syndrome Due to Sarcomatoid Lung Cancer With Pericardial Metastasis Treatment typically focuses on relieving the obstruction through radiation, stenting, or chemotherapy directed at the underlying cancer.

Lymphangitic Carcinomatosis

This is one of the more insidious ways cancer causes breathlessness, and it often catches patients and clinicians off guard. Lymphangitic carcinomatosis happens when cancer cells infiltrate the lymphatic channels inside the lungs. Rather than forming a discrete mass you can point to on a scan, the cancer spreads along the tiny vessels that normally drain fluid from lung tissue. The result is widespread inflammation and stiffening of the lungs, which makes gas exchange profoundly difficult.

The condition can develop from lung, breast, stomach, pancreatic, and prostate cancers, among others. One especially striking case involved a 52-year-old man who came to the hospital with three weeks of worsening shortness of breath. He was found to have stage IV pancreatic cancer that had spread through the lymphatic system into both lungs. Despite aggressive treatment, he deteriorated rapidly and required mechanical ventilation for acute respiratory failure.7Europe PMC / Cureus. A Case of Rapidly Deteriorating Lymphangitic Carcinomatosis in a Patient with Stage IV Pancreatic Cancer – Section: Abstract Lymphangitic carcinomatosis is difficult to treat because there is no single tumor to remove or target, and it tends to be diagnosed at an advanced stage.

Indirect Causes That Have Nothing to Do with the Lungs

Not every cancer-related case of breathlessness involves the lungs directly. Several systemic effects of cancer, and its treatment, can leave a person short of breath even when their lungs look perfectly normal on imaging.

Anemia

Cancer frequently causes anemia, either because the disease itself suppresses red blood cell production, because chemotherapy damages the bone marrow, or because a tumor bleeds slowly and chronically. When hemoglobin drops low enough, the blood simply cannot carry enough oxygen to meet the body’s demands, and breathlessness follows, especially during exertion. Population data show that among people reporting breathlessness and weakness, those with anemia were about 55% more likely to have those symptoms compared to people without anemia.8PMC. Association of Anemia with Clinical Symptoms Commonly Attributed to Anemia—Analysis of Two Population-Based Cohorts – Section: 3.3.4. Dyspnea In cancer patients, anemia can be severe enough to cause breathlessness at rest, not just during activity.

Cancer Cachexia and Muscle Wasting

Cachexia is the severe weight loss and muscle wasting that accompanies many advanced cancers, and it does not spare the muscles you breathe with. Research in animal models of cancer cachexia has shown that the diaphragm, the dome-shaped muscle responsible for drawing air into the lungs, undergoes significant atrophy across all fiber types. Beyond shrinking, the diaphragm also becomes weaker: its force-generating capacity drops substantially, and its ability to perform sustained contractions deteriorates even more. The functional consequence is measurable: animals with cancer cachexia had lower tidal volume under normal conditions and, unlike healthy controls, could not increase their breathing rate, breath depth, or overall ventilation when challenged with a breathing stress test.9FASEB J. Diaphragm and ventilatory dysfunction during cancer cachexia Although these specific measurements come from animal studies, the clinical reality in humans is consistent: patients with cachexia frequently report profound breathlessness that worsens as muscle mass declines.

Phrenic Nerve Damage

The phrenic nerve controls the diaphragm, and tumors in the chest can damage or destroy it. When the nerve stops working on one side, half the diaphragm becomes paralyzed and rises up, reducing the lung’s capacity on that side. This complication occurs in roughly 2% of thymoma surgeries and about 7% of lung cancer surgeries. In locally advanced thymoma where complete tumor removal requires cutting through the phrenic nerve, diaphragm paralysis has been reported in approximately 30% of cases.10Oxford University Press. Impact of Phrenic Nerve Repair Using Intercostal Nerve Graft on Diaphragm Function after Thoracic Tumour Resection – Section: INTRODUCTION The resulting breathing difficulty can be severe enough to require ventilatory support.

Breathing Problems Caused by Cancer Treatment

Sometimes the treatment rather than the cancer itself is what makes breathing hard. This is an important distinction because it changes what needs to happen next, and because patients undergoing treatment deserve to know it is a possibility.

Radiation-Induced Lung Injury

Radiation therapy directed at the chest, whether for lung cancer, breast cancer, lymphoma, or esophageal cancer, can damage healthy lung tissue in the radiation field. The injury follows a timeline: an acute inflammatory phase called radiation pneumonitis can develop weeks to months after treatment, causing cough, fever, and shortness of breath. If the inflammation persists or is severe, it can progress to chronic pulmonary fibrosis, where the lung tissue scars permanently and loses its ability to expand and exchange gases.11PubMed Central. Radiation-Induced Lung Injury-Current Perspectives and Management – Section: Abstract Modern radiation techniques aim to minimize the volume of healthy lung exposed, but the risk is not zero, particularly when the radiation field is large.

Immunotherapy-Related Pneumonitis

Immune checkpoint inhibitors have transformed the treatment of many cancers, but they work by revving up the immune system, and sometimes that immune activation turns against healthy lung tissue. Pneumonitis from these drugs involves inflammation of the lung tissue itself and can range from mild to rapidly fatal. About 40% of patients on immune checkpoint inhibitors experience some form of immune-related side effect, and while lung inflammation is not the most common, it carries a threefold increased risk of requiring intensive care compared to other immune side effects.12PubMed Central. Immune Checkpoint Inhibitor-associated Pneumonitis: A Narrative Review The onset is unpredictable: it can appear within days of the first infusion or months into treatment. The typical window is six to twelve weeks after starting therapy, but vigilance is warranted throughout the entire course of treatment.

Rare but Real Mechanisms

Beyond the major causes listed above, a few less common pathways deserve mention because they can be baffling when they occur. Paraneoplastic syndromes are conditions in which the immune system, triggered by a cancer, attacks parts of the patient’s own nervous system. In one documented case, a woman with breast cancer developed progressive muscle weakness and respiratory failure caused by anti-Ri antibodies, which are antibodies that the cancer provoked and which attacked her neuromuscular system. Her breathing deteriorated to the point of requiring mechanical ventilation, and the diagnosis was only made after other explanations like Guillain-Barré syndrome, myasthenia gravis, and stroke were ruled out.13CHEST. Anti-Ri-Associated Paraneoplastic Neurological Syndrome Presenting as Neuromuscular Weakness and Respiratory Failure in Breast Cancer – Section: DISCUSSION Paraneoplastic respiratory failure is rare, but it is treatable once identified, making awareness of the possibility valuable.

Dyspnea in cancer patients is one of the more common symptoms overall, with especially high prevalence in lung cancer and advanced-stage disease of any type.14Europe PMC. Dyspnea in Oncological Patients: a Brain Teaser – Section: Abstract What makes it complicated from a clinical standpoint is that multiple causes frequently overlap in the same patient. Someone with lung cancer might have a pleural effusion, anemia from chemotherapy, radiation-induced lung damage, and cachexia-related diaphragm weakness all contributing to their breathlessness simultaneously.

Managing Shortness of Breath in Cancer

Treating the underlying cause is always the first priority when possible: draining a pleural effusion, stenting an obstructed airway, transfusing blood for severe anemia, or adjusting a treatment that is causing lung inflammation. But when breathlessness persists despite addressing reversible causes, palliative management becomes essential, and the evidence base here is stronger than many people realize.

For persistent, hard-to-treat breathlessness, opioids are the best-studied pharmacological option. They work not by improving lung function but by changing how the brain processes the sensation of air hunger. The proposed mechanisms include reducing the brain’s respiratory drive and its associated distress signals, altering the central perception of breathlessness, affecting opioid receptors within the lungs themselves, and reducing anxiety.15PubMed. Opioids for refractory dyspnea Because people respond differently, guidelines recommend starting with a low dose and titrating upward. When used appropriately for breathlessness rather than pain, opioids at these doses are considered safe and do not typically hasten death, which is a persistent misconception that sometimes prevents their use.16PubMed Central. Management of dyspnea in palliative care – Section: Abstract

Non-drug approaches also have genuine evidence behind them. The ASCO guideline on dyspnea management in advanced cancer recommends airflow interventions such as a handheld fan directed at the cheek, supplemental oxygen for patients whose blood oxygen is actually low, and psychoeducational or self-management strategies.17PubMed. Management of Dyspnea in Advanced Cancer: ASCO Guideline – Section: RECOMMENDATIONS The fan trick sounds too simple to work, but the cool air stimulates facial nerve receptors that send calming signals to the brainstem, and multiple trials have confirmed its benefit. Exercise programs and pulmonary rehabilitation, adapted to the patient’s capacity, can also improve the efficiency of whatever breathing muscles remain functional.

When Breathlessness Is the First Sign

One of the more unsettling aspects of cancer-related breathlessness is that it sometimes appears before anyone knows cancer is present. The 75-year-old former smoker described earlier had no previous cancer diagnosis; her shortness of breath was the thread that led to the discovery of three lung tumors. The man with pancreatic cancer came to the hospital for breathing trouble, not abdominal complaints. In both cases, the cancer had already reached an advanced stage by the time breathing symptoms prompted investigation.

This does not mean every episode of unexplained breathlessness signals cancer. Far more common causes include asthma, heart failure, deconditioning, and anxiety. But breathlessness that is new, progressive, unexplained by an existing condition, and accompanied by other red flags like unintentional weight loss, persistent cough, or blood in the sputum warrants thorough evaluation. Chest imaging, blood work including a complete blood count, and sometimes bronchoscopy or CT scans are the tools clinicians use to rule cancer in or out. The message is not to panic at every bout of shortness of breath, but to take seriously the kind that worsens over weeks and does not have an obvious explanation.